Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	neuron migration	ZNF609 KIF26A GATA3 ULK1 ZMIZ1 ROBO3 RAPGEF2 MAPK8IP3	4.65e-07	218	66	8	GO:0001764
GeneOntologyBiologicalProcess	negative regulation of developmental growth	MAP2 ATXN2 RTN4 ULK1 ULK2 RAI1	3.10e-06	126	66	6	GO:0048640
GeneOntologyBiologicalProcess	somatic sensory system development	ULK1 ULK2	1.01e-05	2	66	2	GO:0160038
GeneOntologyBiologicalProcess	negative regulation of axonogenesis	MAP2 RTN4 ULK1 ULK2	4.64e-05	62	66	4	GO:0050771
GeneOntologyBiologicalProcess	regulation of neuron migration	ZNF609 KIF26A RAPGEF2 MAPK8IP3	4.64e-05	62	66	4	GO:2001222
GeneOntologyBiologicalProcess	regulation of cellular component size	FCHSD2 BAIAP2L1 MAP2 RTN4 LRRC8A ULK1 ULK2 HCK	6.25e-05	426	66	8	GO:0032535
GeneOntologyBiologicalProcess	positive regulation of neuron migration	ZNF609 RAPGEF2 MAPK8IP3	6.84e-05	25	66	3	GO:2001224
GeneOntologyBiologicalProcess	regulation of protein localization to endoplasmic reticulum	RTN4 NACA	1.00e-04	5	66	2	GO:1905550
GeneOntologyBiologicalProcess	developmental growth	MAP2 ATXN2 RTN4 NACA GATA3 TNS2 ULK1 ZMIZ1 PPP1R13L ULK2 RAI1	1.36e-04	911	66	11	GO:0048589
GeneOntologyBiologicalProcess	neuron development	MAP2 NRL ATXN2 KIF26A RTN4 GATA3 PCARE ULK1 ZMIZ1 CTNND2 ROBO3 RAPGEF2 ULK2 MAPK8IP3	1.80e-04	1463	66	14	GO:0048666
GeneOntologyBiologicalProcess	neuron projection morphogenesis	MAP2 ATXN2 RTN4 GATA3 ULK1 CTNND2 ROBO3 RAPGEF2 ULK2 MAPK8IP3	2.19e-04	802	66	10	GO:0048812
GeneOntologyBiologicalProcess	negative regulation of neurogenesis	MAP2 RTN4 ULK1 RAPGEF2 ULK2	2.32e-04	173	66	5	GO:0050768
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	MAP2 ATXN2 RTN4 GATA3 ULK1 CTNND2 ROBO3 RAPGEF2 ULK2 MAPK8IP3	2.59e-04	819	66	10	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	MAP2 ATXN2 RTN4 GATA3 ULK1 CTNND2 ROBO3 RAPGEF2 ULK2 MAPK8IP3	2.78e-04	826	66	10	GO:0048858
GeneOntologyBiologicalProcess	negative regulation of growth	MAP2 ATXN2 RTN4 ULK1 ULK2 RAI1	2.88e-04	283	66	6	GO:0045926
GeneOntologyBiologicalProcess	negative regulation of nervous system development	MAP2 RTN4 ULK1 RAPGEF2 ULK2	3.08e-04	184	66	5	GO:0051961
GeneOntologyBiologicalProcess	regulation of developmental growth	MAP2 ATXN2 RTN4 NACA ULK1 ULK2 RAI1	3.88e-04	421	66	7	GO:0048638
GeneOntologyBiologicalProcess	growth	MAP2 ATXN2 KIF26A RTN4 NACA GATA3 TNS2 ULK1 ZMIZ1 PPP1R13L ULK2 RAI1	4.89e-04	1235	66	12	GO:0040007
GeneOntologyBiologicalProcess	vasculogenesis	AMOT RTN4 ZMIZ1 RAPGEF2	5.58e-04	118	66	4	GO:0001570
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	MAP2 RTN4 GATA3 ULK1 CTNND2 ROBO3 RAPGEF2 ULK2 MAPK8IP3	6.02e-04	748	66	9	GO:0048667
GeneOntologyBiologicalProcess	regulation of extent of cell growth	MAP2 RTN4 ULK1 ULK2	6.33e-04	122	66	4	GO:0061387
GeneOntologyBiologicalProcess	negative regulation of collateral sprouting	ULK1 ULK2	6.52e-04	12	66	2	GO:0048671
GeneOntologyBiologicalProcess	regulation of cell development	FOXN1 ZNF609 MAP2 RTN4 NACA GATA3 CD46 ULK1 ZMIZ1 RAPGEF2 ULK2	6.56e-04	1095	66	11	GO:0060284
GeneOntologyBiologicalProcess	regulation of neuron projection development	MAP2 KIF26A RTN4 GATA3 ULK1 ROBO3 RAPGEF2 ULK2	7.25e-04	612	66	8	GO:0010975
GeneOntologyBiologicalProcess	regulation of cell size	MAP2 RTN4 LRRC8A ULK1 ULK2	7.69e-04	225	66	5	GO:0008361
GeneOntologyBiologicalProcess	regulation of anatomical structure size	FCHSD2 BAIAP2L1 MAP2 RTN4 LRRC8A ULK1 ULK2 HCK	7.72e-04	618	66	8	GO:0090066
GeneOntologyBiologicalProcess	regulation of T cell differentiation	FOXN1 ZNF609 GATA3 CD46 ZMIZ1	7.84e-04	226	66	5	GO:0045580
GeneOntologyBiologicalProcess	positive regulation of actin filament polymerization	FCHSD2 BAIAP2L1 HCK	8.95e-04	59	66	3	GO:0030838
GeneOntologyBiologicalProcess	negative regulation of cell projection organization	MAP2 RTN4 ULK1 RAPGEF2 ULK2	8.99e-04	233	66	5	GO:0031345
GeneOntologyBiologicalProcess	positive regulation of cell differentiation	FOXN1 ZNF609 ATOH8 RTN4 GATA3 LRRC8A CD46 ZMIZ1 RAPGEF2 PPP1R13L MAPK8IP3	9.21e-04	1141	66	11	GO:0045597
GeneOntologyBiologicalProcess	axon extension	MAP2 RTN4 ULK1 ULK2	9.24e-04	135	66	4	GO:0048675
GeneOntologyCellularComponent	anchoring junction	FCHSD2 BAIAP2L1 AMOT RTN4 LPP TNS2 CD46 CTNND2 RAPGEF2 TRIM29 HCK ZYX	4.80e-05	976	66	12	GO:0070161
Domain	Ser/Thr_kinase_C	ULK1 ULK2	1.16e-05	2	64	2	IPR022708
Domain	DUF3543	ULK1 ULK2	1.16e-05	2	64	2	PF12063
Domain	Ser/Thr_kin_STPK_Ulk-1/2	ULK1 ULK2	1.16e-05	2	64	2	IPR016237
Domain	CLTH	RANBP10 RANBP9	1.72e-04	6	64	2	PF10607
Domain	CRA	RANBP10 RANBP9	1.72e-04	6	64	2	SM00757
Domain	CTLH/CRA	RANBP10 RANBP9	1.72e-04	6	64	2	IPR024964
Domain	CRA_dom	RANBP10 RANBP9	1.72e-04	6	64	2	IPR013144
Domain	zf-MIZ	ZMIZ2 ZMIZ1	2.40e-04	7	64	2	PF02891
Domain	ZF_SP_RING	ZMIZ2 ZMIZ1	2.40e-04	7	64	2	PS51044
Domain	SH3_1	FCHSD2 BAIAP2L1 ARHGEF9 PPP1R13L HCK	2.46e-04	164	64	5	PF00018
Domain	Znf_MIZ	ZMIZ2 ZMIZ1	3.19e-04	8	64	2	IPR004181
Domain	CTLH	RANBP10 RANBP9	4.10e-04	9	64	2	SM00668
Domain	LisH	RANBP10 RANBP9	4.10e-04	9	64	2	PF08513
Domain	SPAN-X_fam	SPANXD SPANXC	5.11e-04	10	64	2	IPR010007
Domain	SPAN-X	SPANXD SPANXC	5.11e-04	10	64	2	PF07458
Domain	CTLH_C	RANBP10 RANBP9	5.11e-04	10	64	2	IPR006595
Domain	CTLH	RANBP10 RANBP9	5.11e-04	10	64	2	PS50897
Domain	SH3	FCHSD2 BAIAP2L1 ARHGEF9 PPP1R13L HCK	8.65e-04	216	64	5	SM00326
Domain	SH3	FCHSD2 BAIAP2L1 ARHGEF9 PPP1R13L HCK	8.65e-04	216	64	5	PS50002
Domain	SH3_domain	FCHSD2 BAIAP2L1 ARHGEF9 PPP1R13L HCK	9.39e-04	220	64	5	IPR001452
Domain	Ca/CaM-dep_Ca-dep_prot_Kinase	CAMKK2 ULK1 ULK2	1.71e-03	69	64	3	IPR020636
Domain	-	LPP SCEL ZYX	1.78e-03	70	64	3	2.10.110.10
Domain	Znf_LIM	LPP SCEL ZYX	1.86e-03	71	64	3	IPR001781
Domain	LIM_DOMAIN_1	LPP SCEL ZYX	1.86e-03	71	64	3	PS00478
Domain	LIM_DOMAIN_2	LPP SCEL ZYX	1.86e-03	71	64	3	PS50023
Domain	LIM	LPP SCEL ZYX	1.86e-03	71	64	3	SM00132
Domain	SH3_9	FCHSD2 BAIAP2L1 PPP1R13L	2.43e-03	78	64	3	PF14604
Domain	LisH	RANBP10 RANBP9	4.13e-03	28	64	2	SM00667
Domain	LisH	RANBP10 RANBP9	4.13e-03	28	64	2	IPR006594
Domain	LISH	RANBP10 RANBP9	4.13e-03	28	64	2	PS50896
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZNF609 CAMKK2 KIF26A AMOT PLCH2 RNF44 RTN4 NACA LRRC8A BSN KDM6B RGP1 RAI1	2.42e-11	529	67	13	14621295
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	RANBP10 PCNX3 KIF26A ZMIZ2 POLR2A MED14 ULK1 KDM6B POM121C ULK2 PRRC2B RAI1 MAPK8IP3	1.62e-07	1105	67	13	35748872
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZNF469 ZNF609 POLR2A RANBP9 SCEL RAPGEF2 SRRM2 POM121C NCKAP5L PDHX AFF4 PRRC2B RAI1	1.81e-07	1116	67	13	31753913
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	FAM168A LPP CTNND2 BSN PPP1R13L NCKAP5L PRRC2B	2.18e-07	218	67	7	33378226
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FCHSD2 CAMKK2 FAM168A ARHGEF9 ULK1 SRRM2 ULK2 PRRC2B	1.17e-06	407	67	8	12693553
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	ZNF469 ZNF609 BAIAP2L1 ATXN2 PLCH2 ZMIZ2 BSN POM121C	1.76e-06	430	67	8	35044719
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	RANBP10 ATXN2 RANBP9 CTNND2 RAPGEF2 CCDC6 BSN AFF4 PRRC2B RAI1 MAPK8IP3	2.16e-06	963	67	11	28671696
Pubmed	Conservation of structure, function and inhibitor binding in UNC-51-like kinase 1 and 2 (ULK1/2).	ULK1 ULK2	3.66e-06	2	67	2	30782972
Pubmed	Identification of mouse ULK1, a novel protein kinase structurally related to C. elegans UNC-51.	ULK1 ULK2	3.66e-06	2	67	2	9600096
Pubmed	Distinct functions of Ulk1 and Ulk2 in the regulation of lipid metabolism in adipocytes.	ULK1 ULK2	3.66e-06	2	67	2	24135897
Pubmed	The requirement of uncoordinated 51-like kinase 1 (ULK1) and ULK2 in the regulation of autophagy.	ULK1 ULK2	3.66e-06	2	67	2	21460635
Pubmed	Coxsackievirus infection induces a non-canonical autophagy independent of the ULK and PI3K complexes.	ULK1 ULK2	3.66e-06	2	67	2	33149253
Pubmed	ULK1/2 Constitute a Bifurcate Node Controlling Glucose Metabolic Fluxes in Addition to Autophagy.	ULK1 ULK2	3.66e-06	2	67	2	27153534
Pubmed	Association of LPP and ZMIZ1 Gene Polymorphism with Celiac Disease in Subjects from Punjab, Pakistan.	LPP ZMIZ1	3.66e-06	2	67	2	39062631
Pubmed	Spatial and temporal expression of Zimp7 and Zimp10 PIAS-like proteins in the developing mouse embryo.	ZMIZ2 ZMIZ1	3.66e-06	2	67	2	18053775
Pubmed	Regulation of nutrient-sensitive autophagy by uncoordinated 51-like kinases 1 and 2.	ULK1 ULK2	3.66e-06	2	67	2	23291478
Pubmed	Ulk1, Not Ulk2, Is Required for Exercise Training-Induced Improvement of Insulin Response in Skeletal Muscle.	ULK1 ULK2	3.66e-06	2	67	2	34658916
Pubmed	A mouse serine/threonine kinase homologous to C. elegans UNC51 functions in parallel fiber formation of cerebellar granule neurons.	ULK1 ULK2	3.66e-06	2	67	2	10624947
Pubmed	A human MAP kinase interactome.	KIF26A ARHGEF9 RANBP9 RAPGEF2 POM121C NCKAP5L HCK ZYX	4.35e-06	486	67	8	20936779
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	ZNF469 AMOT RTN4 POLR2A NACA CCDC6 BSN SRRM2 ZYX	4.45e-06	653	67	9	33742100
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	CAMKK2 MAP2 RTN4 CTNND2 BSN SRRM2 MAPK8IP3	4.82e-06	347	67	7	17114649
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ZNF609 ATXN2 POLR2A LPP TNS2 CCDC6 PPP1R13L SRRM2 NCKAP5L ZYX PRRC2B	4.89e-06	1049	67	11	27880917
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	BAIAP2L1 MAP2 AMOT LPP RAPGEF2 CCDC6 MCRIP1 SRRM2 NCKAP5L ZYX	5.69e-06	861	67	10	36931259
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	MAP2 CTNND2 BSN SRRM2 PRRC2B MAPK8IP3	5.72e-06	231	67	6	16452087
Pubmed	Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.	POLR2A LPP CCDC6 SRRM2 HCK	6.05e-06	133	67	5	15144186
Pubmed	A yeast two-hybrid screen reveals that osteopontin associates with MAP1A and MAP1B in addition to other proteins linked to microtubule stability, apoptosis and protein degradation in the human brain.	NACA RANBP9 RAPGEF2 AFF4	9.33e-06	68	67	4	22779921
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	RANBP10 ATXN2 NACA RANBP9 CCDC6 ZYX PDHX PRRC2B	1.08e-05	551	67	8	34728620
Pubmed	Long non‑coding RNA growth arrest‑specific 5 (GAS5) acts as a tumor suppressor by promoting autophagy in breast cancer.	ULK1 ULK2	1.10e-05	3	67	2	32705220
Pubmed	Ammonia-induced autophagy is independent of ULK1/ULK2 kinases.	ULK1 ULK2	1.10e-05	3	67	2	21690395
Pubmed	The cancer-testis antigens SPANX-A/C/D and CTAG2 promote breast cancer invasion.	SPANXD SPANXC	1.10e-05	3	67	2	26895102
Pubmed	Withdrawal of essential amino acids increases autophagy by a pathway involving Ca2+/calmodulin-dependent kinase kinase-β (CaMKK-β).	CAMKK2 ULK1	1.10e-05	3	67	2	23027865
Pubmed	Perinatal versus adult loss of ULK1 and ULK2 distinctly influences cardiac autophagy and function.	ULK1 ULK2	1.10e-05	3	67	2	35104184
Pubmed	Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer.	ULK1 ULK2	1.10e-05	3	67	2	39213022
Pubmed	Expression of a ULK1/2 binding-deficient ATG13 variant can partially restore autophagic activity in ATG13-deficient cells.	ULK1 ULK2	1.10e-05	3	67	2	26213203
Pubmed	ULK complex organization in autophagy by a C-shaped FIP200 N-terminal domain dimer.	ULK1 ULK2	1.10e-05	3	67	2	32516362
Pubmed	Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signaling.	CAMKK2 ULK1	1.10e-05	3	67	2	33531625
Pubmed	Thyroid hormone induction of mitochondrial activity is coupled to mitophagy via ROS-AMPK-ULK1 signaling.	CAMKK2 ULK1	1.10e-05	3	67	2	26103054
Pubmed	AFF4 regulates osteogenic potential of human periodontal ligament stem cells via mTOR-ULK1-autophagy axis.	ULK1 AFF4	1.10e-05	3	67	2	37731335
Pubmed	An ULK1/2-PXN mechanotransduction pathway suppresses breast cancer cell migration.	ULK1 ULK2	1.10e-05	3	67	2	37846507
Pubmed	The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor.	ZMIZ2 ZMIZ1	1.10e-05	3	67	2	17584785
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	ZNF609 AMOT ZMIZ2 ZMIZ1 PRRC2B	1.16e-05	152	67	5	38360978
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	ZNF609 SUGP1 MED14 AFF4 PRRC2B RAI1	1.33e-05	268	67	6	33640491
Pubmed	BCOR modulates transcriptional activity of a subset of glucocorticoid receptor target genes involved in cell growth and mobility.	ZNF609 SUGP1 PRRC2B	1.34e-05	24	67	3	33722704
Pubmed	Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt.	RTN4 POLR2A RANBP9 MED14 SRRM2 PRRC2B	1.42e-05	271	67	6	25737280
Pubmed	Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia.	MAP2 RTN4 CTNND2 BSN	2.16e-05	84	67	4	19165527
Pubmed	Phosphorylation of the exchange factor DENND3 by ULK in response to starvation activates Rab12 and induces autophagy.	ULK1 ULK2	2.19e-05	4	67	2	25925668
Pubmed	Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPM.	RANBP10 RANBP9	2.19e-05	4	67	2	12147692
Pubmed	A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127.	FOXN1 GATA3	2.19e-05	4	67	2	17013389
Pubmed	Nuclear import of LASP-1 is regulated by phosphorylation and dynamic protein-protein interactions.	LPP ZYX	2.19e-05	4	67	2	22665060
Pubmed	ULK1 and ULK2 Regulate Stress Granule Disassembly Through Phosphorylation and Activation of VCP/p97.	ULK1 ULK2	2.19e-05	4	67	2	30979586
Pubmed	Modeling by disruption and a selected-for partner for the nude locus.	FOXN1 AFF4	2.19e-05	4	67	2	33369874
Pubmed	Upregulation of human autophagy-initiation kinase ULK1 by tumor suppressor p53 contributes to DNA-damage-induced cell death.	ULK1 ULK2	2.19e-05	4	67	2	21475306
Pubmed	FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells.	ULK1 ULK2	2.19e-05	4	67	2	18443221
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	ZNF609 ATXN2 SUSD2 ZMIZ1 POM121C PRRC2B RAI1	2.85e-05	457	67	7	32344865
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	ZNF609 BAIAP2L1 POLR2A NACA RANBP9 CCDC6 SRRM2	3.49e-05	472	67	7	38943005
Pubmed	Copper is an essential regulator of the autophagic kinases ULK1/2 to drive lung adenocarcinoma.	ULK1 ULK2	3.64e-05	5	67	2	32203415
Pubmed	The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity.	ZMIZ2 ZMIZ1	3.64e-05	5	67	2	16777850
Pubmed	Polymorphisms in RAI and in genes of nucleotide and base excision repair are not associated with risk of testicular cancer.	PPP1R13L RAI1	3.64e-05	5	67	2	15885892
Pubmed	Atg101, a novel mammalian autophagy protein interacting with Atg13.	ULK1 ULK2	3.64e-05	5	67	2	19597335
Pubmed	Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death.	ULK1 ULK2	3.64e-05	5	67	2	22493260
Pubmed	Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27.	SPANXD SPANXC	3.64e-05	5	67	2	16251457
Pubmed	Binding of liganded vitamin D receptor to the vitamin D receptor interacting protein coactivator complex induces interaction with RNA polymerase II holoenzyme.	POLR2A MED14	3.64e-05	5	67	2	10753860
Pubmed	Sexually dimorphic gene expression of the Zimp7 and Zimp10 genes in embryonic gonads.	ZMIZ2 ZMIZ1	3.64e-05	5	67	2	19931425
Pubmed	Differential nuclear localization of the cancer/testis-associated protein, SPAN-X/CTp11, in transfected cells and in 50% of human spermatozoa.	SPANXD SPANXC	3.64e-05	5	67	2	11133693
Pubmed	Genomic organization, incidence, and localization of the SPAN-x family of cancer-testis antigens in melanoma tumors and cell lines.	SPANXD SPANXC	3.64e-05	5	67	2	14734458
Pubmed	A role for BCL2L13 and autophagy in germline purifying selection of mtDNA.	ULK1 ULK2	3.64e-05	5	67	2	36608143
Pubmed	SPANX gene variation in fertile and infertile males.	SPANXD SPANXC	3.64e-05	5	67	2	20073942
Pubmed	The Noncanonical Role of ULK/ATG1 in ER-to-Golgi Trafficking Is Essential for Cellular Homeostasis.	ULK1 ULK2	3.64e-05	5	67	2	27203176
Pubmed	Akt1-mediated Gata3 phosphorylation controls the repression of IFNγ in memory-type Th2 cells.	FOXN1 GATA3	3.64e-05	5	67	2	27053161
Pubmed	JNK/stress-activated protein kinase associated protein 1 is required for early development of telencephalic commissures in embryonic brains.	MAP2 MAPK8IP3	3.64e-05	5	67	2	21685723
Pubmed	The human SPANX multigene family: genomic organization, alignment and expression in male germ cells and tumor cell lines.	SPANXD SPANXC	3.64e-05	5	67	2	12758128
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	ZNF609 RAPGEF2 KDM6B SRRM2	5.00e-05	104	67	4	9205841
Pubmed	Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	AMOT RNF44 TNS2 MAPK8IP3	5.00e-05	104	67	4	10470851
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	POLR2A GATA3 MED14 SRRM2 POM121C AFF4	5.13e-05	341	67	6	32971831
Pubmed	Role of Unc51.1 and its binding partners in CNS axon outgrowth.	ULK1 ULK2	5.46e-05	6	67	2	15014045
Pubmed	The Calmodulin Binding Region of the Synaptic Vesicle Protein Mover Is Required for Homomeric Interaction and Presynaptic Targeting.	MAP2 BSN	5.46e-05	6	67	2	31787876
Pubmed	A novel role for protein inhibitor of activated STAT (PIAS) proteins in modulating the activity of Zimp7, a novel PIAS-like protein, in androgen receptor-mediated transcription.	ZMIZ2 ZMIZ1	5.46e-05	6	67	2	20159969
Pubmed	Annexin A2 Regulates Autophagy in Pseudomonas aeruginosa Infection through the Akt1-mTOR-ULK1/2 Signaling Pathway.	ULK1 ULK2	5.46e-05	6	67	2	26371245
Pubmed	The ULK1 complex mediates MTORC1 signaling to the autophagy initiation machinery via binding and phosphorylating ATG14.	ULK1 ULK2	5.46e-05	6	67	2	27046250
Pubmed	ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery.	ULK1 ULK2	5.46e-05	6	67	2	19225151
Pubmed	Structure of excitatory synapses and GABAA receptor localization at inhibitory synapses are regulated by neuroplastin-65.	MAP2 BSN	5.46e-05	6	67	2	24554721
Pubmed	Kinase-inactivated ULK proteins inhibit autophagy via their conserved C-terminal domains using an Atg13-independent mechanism.	ULK1 ULK2	5.46e-05	6	67	2	18936157
Pubmed	Unc-51-like kinase 1/2-mediated endocytic processes regulate filopodia extension and branching of sensory axons.	ULK1 ULK2	5.46e-05	6	67	2	17389358
Pubmed	ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes.	POLR2A MED14 SRRM2 PRRC2B	5.59e-05	107	67	4	20508642
Pubmed	Interaction network of human early embryonic transcription factors.	ZNF609 ZMIZ2 ZMIZ1 POM121C PRRC2B RAI1	6.02e-05	351	67	6	38297188
Pubmed	Gbx2 is essential for maintaining thalamic neuron identity and repressing habenular characters in the developing thalamus.	KIF26A GATA3 ROBO3	6.42e-05	40	67	3	26297811
Pubmed	Next-generation sequencing to generate interactome datasets.	FCHSD2 FAM168A RTN4 RANBP9 SCEL TRIM29 HCK ZYX PDHX PRRC2B	6.59e-05	1147	67	10	21516116
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	RTN4 POLR2A LPP NACA SUGP1 POM121C ZYX AFF4 PRRC2B	7.41e-05	934	67	9	33916271
Pubmed	Autophagy-Independent Lysosomal Targeting Regulated by ULK1/2-FIP200 and ATG9.	ULK1 ULK2	7.63e-05	7	67	2	28877469
Pubmed	Hepatitis C virus triggers Golgi fragmentation and autophagy through the immunity-related GTPase M.	ULK1 ULK2	7.63e-05	7	67	2	28389568
Pubmed	Regional localization of the nu mutation on mouse chromosome 11.	FOXN1 POLR2A	7.63e-05	7	67	2	8423056
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ZNF609 POLR2A LPP NACA SUGP1 PPP1R13L MCRIP1 NCKAP5L	8.17e-05	733	67	8	34672954
Pubmed	Human transcription factor protein interaction networks.	ZNF609 ATXN2 ZMIZ2 NACA GATA3 SUGP1 ZMIZ1 MCRIP1 SRRM2 POM121C PRRC2B	8.40e-05	1429	67	11	35140242
Pubmed	Diverse alternative back-splicing and alternative splicing landscape of circular RNAs.	POLR2A PRRC2B	1.02e-04	8	67	2	27365365
Pubmed	Diversity of two forms of DNA methylation in the brain.	MAP2 POLR2A	1.02e-04	8	67	2	24653733
Pubmed	Human Polymerase-Associated Factor complex (PAFc) connects the Super Elongation Complex (SEC) to RNA polymerase II on chromatin.	POLR2A AFF4	1.02e-04	8	67	2	21873227
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	BAIAP2L1 RTN4 LPP SCEL PPP1R13L TRIM29 ZYX	1.08e-04	565	67	7	25468996
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	MAP2 RTN4 NACA CTNND2 SRRM2	1.15e-04	246	67	5	15345747
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	RTN4 LPP TNS2 CCDC6 PPP1R13L MCRIP1 SRRM2	1.18e-04	573	67	7	28330616
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZNF609 FAM168A MAP2 ATXN2 LPP ARHGEF9 ZMIZ1 RAPGEF2 AFF4 RAI1 MAPK8IP3	1.21e-04	1489	67	11	28611215
Interaction	TNKS interactions	AMOT PLCH2 RANBP9 TNS2 RAPGEF2 MAPK8IP3	1.34e-06	105	67	6	int:TNKS
Interaction	NEDD4 interactions	RANBP10 CAMKK2 BAIAP2L1 MAP2 AMOT POLR2A NACA TTYH2 ULK1 RAPGEF2 KDM6B	1.64e-06	544	67	11	int:NEDD4
Interaction	LPXN interactions	ATXN2 LPP TNS2 RAPGEF2 CCDC6 ZYX	2.28e-06	115	67	6	int:LPXN
Interaction	UNK interactions	ATXN2 RTN4 POLR2A RANBP9 MED14 CCDC6 MCRIP1 SRRM2 PRRC2B	7.92e-06	408	67	9	int:UNK
Interaction	SEC16A interactions	ATXN2 AMOT ULK1 CCDC6 PPP1R13L TRIM29 ULK2 ZYX PRRC2B	1.12e-05	426	67	9	int:SEC16A
Interaction	CRX interactions	ZNF609 NRL ZMIZ2 TNS2 ZMIZ1 PRRC2B RAI1	2.12e-05	254	67	7	int:CRX
Interaction	PIN1 interactions	FOXN1 AMOT ZMIZ2 POLR2A TNS2 CCDC6 SRRM2 RAI1	3.88e-05	383	67	8	int:PIN1
Interaction	NRXN1 interactions	MAP2 RTN4 CTNND2 BSN TRIM29	6.49e-05	127	67	5	int:NRXN1
Interaction	NR3C1 interactions	RTN4 RANBP9 SUGP1 MED14 CTNND2 CCDC6 BSN MCRIP1 POM121C PDHX PRRC2B RAI1	7.78e-05	974	67	12	int:NR3C1
Cytoband	Xq27.1	SPANXD SPANXC CXorf66	1.99e-06	17	67	3	Xq27.1
Cytoband	Ensembl 112 genes in cytogenetic band chrXq27	SPANXD SPANXC CXorf66	3.29e-04	91	67	3	chrXq27
GeneFamily	Zinc fingers MIZ-type	ZMIZ2 ZMIZ1	1.05e-04	7	41	2	85
GeneFamily	LIM domain containing	LPP SCEL ZYX	3.22e-04	59	41	3	1218
GeneFamily	Autophagy related	ULK1 ULK2	2.53e-03	33	41	2	1022
ToppCell	facs-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLCH2 SCEL KDM6B PPP1R13L TRIM29 SRRM2	4.49e-07	192	67	6	1f81b356520b5506051383d37fae204d59795336
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 ATOH8 SUSD2 SCEL PPP1R13L	7.87e-06	181	67	5	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLCH2 POLR2A KDM6B TRIM29 NCKAP5L	8.98e-06	186	67	5	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 ATOH8 SUSD2 SCEL PPP1R13L	8.98e-06	186	67	5	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLCH2 POLR2A KDM6B TRIM29 NCKAP5L	9.70e-06	189	67	5	965e0e388251e7318f8b463816dc96ccb4658677
ToppCell	facs-Spleen-nan-18m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLCH2 SCEL KDM6B TRIM29 SRRM2	1.10e-05	194	67	5	842636fcc64eb8f04eb4e30b6eb70410050880e9
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4\|TCGA-Prostate / Sample_Type by Project: Shred V9	FCHSD2 ZNF469 TTYH2 NCKAP5L ZYX	1.13e-05	195	67	5	5562665dd3beb70e2358aa32611a337bef5731c1
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HOXD1 BAIAP2L1 MAP2 SUSD2 SCEL	1.21e-05	198	67	5	691a2f1779225e5519155460eeb6a2aac5f67a92
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HOXD1 BAIAP2L1 MAP2 SUSD2 SCEL	1.21e-05	198	67	5	aed0476248e9637897eefb1623ec4035f2dacd82
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	HOXD1 BAIAP2L1 MAP2 SUSD2 SCEL	1.21e-05	198	67	5	e115eea04012e9e492e923ed080e1723c38d14fd
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HOXD1 BAIAP2L1 MAP2 SUSD2 SCEL	1.21e-05	198	67	5	33d1e0b6f57663544bee0ffdde83a65da764d44c
ToppCell	Severe_COVID-19-Epithelial-AT1/AT2\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	HOXD1 BAIAP2L1 MAP2 SUSD2 SCEL	1.21e-05	198	67	5	43e33d28d9de5033bd00d39be953542a225236ed
ToppCell	Skin\|World / Skin and Kidney Cells in Lupus Nephritis Patients.	FOXN1 GATA3 SCEL PPP1R13L TRIM29	1.24e-05	199	67	5	6be1340413ee868c610b6e3f58c65b493eb22bb5
ToppCell	AT1-AT2_cells-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	MAP2 HIF3A SCEL CTNND2	6.77e-05	145	67	4	cd5de30fd948024e3ad043c9411ce9f2722178b2
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Spp1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	NRL RUBCNL ROBO3	7.41e-05	54	67	3	98b31718fa200432cf86b59a52484da101219f96
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Spp1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	NRL RUBCNL ROBO3	7.41e-05	54	67	3	872e7374dac64be2c8ebe71e88a2ec6814168d89
ToppCell	AT1-AT2_cells-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	HOXD1 MAP2 SCEL CTNND2	8.77e-05	155	67	4	010e45ef4b505bf419ea41e4d1619521d1c78319
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTYH2 KDM6B SRRM2 SERPINA9	1.02e-04	161	67	4	d02f8c01b26158a06e109eb603b0fe76372ec983
ToppCell	P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	BAIAP2L1 MAP2 SCEL HCK	1.20e-04	168	67	4	8c8dbdbc7053f34e4ca0c5067af502fbea109fc1
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP2 SUSD2 SCEL CTNND2	1.22e-04	169	67	4	cd16e8462ee09877be962fbd9a3badcb825820b0
ToppCell	356C-Epithelial_cells-Epithelial-E_(AT2)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	BAIAP2L1 ATOH8 SUSD2 SCEL	1.25e-04	170	67	4	4cd3b7e43a061948084c01713ae141b5c2c07d89
ToppCell	356C-Epithelial_cells-Epithelial-E_(AT2)\|356C / Donor, Lineage, Cell class and subclass (all cells)	BAIAP2L1 ATOH8 SUSD2 SCEL	1.25e-04	170	67	4	36c9f7f98612a72dc511c8da4358d67444f6bcf4
ToppCell	PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FOXN1 SCEL PPP1R13L TRIM29	1.34e-04	173	67	4	1b2508cc890430bd4b2cf232c633928edb86c57e
ToppCell	PND07-Epithelial-Epithelial_Airway-Basal-Basal\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FOXN1 SCEL PPP1R13L TRIM29	1.59e-04	181	67	4	6b43dcaeeb02ad5900772b6f16f1581847050e38
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FCHSD2 KIF26A AMOT ATOH8	1.59e-04	181	67	4	136b0c60680068838d184d32aa99d7bea8718dbc
ToppCell	PND07-Epithelial-Epithelial_Airway-Basal\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FOXN1 SCEL PPP1R13L TRIM29	1.59e-04	181	67	4	f50561fdacfb83ba85fe6476e7cbc2bad1ebc826
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 ATOH8 SUSD2 SCEL	1.63e-04	182	67	4	cc79e0cc21e2fdc4ef77f052818d27b9f707aec1
ToppCell	COPD-Epithelial-ATI\|World / Disease state, Lineage and Cell class	MAP2 ATOH8 SUSD2 SCEL	1.63e-04	182	67	4	e95d946a43b1579af199900bb0e3eacbb9d65300
ToppCell	COVID-19-APC-like-Dendritic_cells\|COVID-19 / group, cell type (main and fine annotations)	FCHSD2 RUBCNL TTYH2 HCK	1.66e-04	183	67	4	703364836b42aa6ac6c68b42b700ac23c4a1afc7
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 ATOH8 SUSD2 SCEL	1.66e-04	183	67	4	274483009b309289e4cb84beedf6806430db6ff6
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 ATOH8 SUSD2 SCEL	1.66e-04	183	67	4	ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCell	10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-basophil\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ATOH8 ZMIZ2 KDM6B RAI1	1.66e-04	183	67	4	f9a3af96c0fb7d5c4d7df6db8b2c42e322418c08
ToppCell	COVID-19-APC-like\|COVID-19 / group, cell type (main and fine annotations)	FCHSD2 RUBCNL TTYH2 HCK	1.66e-04	183	67	4	b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	MAP2 ATOH8 SCEL CTNND2	1.66e-04	183	67	4	6821dca076318115d360ff426eb1218cfe104063
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 ATOH8 SCEL PPP1R13L	1.73e-04	185	67	4	3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b
ToppCell	droplet-Skin\|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA3 SCEL PPP1R13L TRIM29	1.73e-04	185	67	4	657fd191ed160f8620d57b33820ec7222806f289
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 ATOH8 SCEL PPP1R13L	1.73e-04	185	67	4	c82eab551f65ecebe6db908eda9f9eb3414693c7
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POLR2A LPP TRIM29 AFF4	1.73e-04	185	67	4	eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCell	COPD-Epithelial-ATI\|COPD / Disease state, Lineage and Cell class	MAP2 ATOH8 SUSD2 SCEL	1.77e-04	186	67	4	df0977f6f48a2d4e11b59971f098b01204242f0f
ToppCell	5'-Adult-LymphNode-Hematopoietic-Myeloid-cDC1\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RUBCNL TTYH2 HCK ZYX	1.81e-04	187	67	4	8249b2a69c728e4e04fb14b490c320e644d2252f
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BAIAP2L1 ATOH8 SCEL PPP1R13L	1.81e-04	187	67	4	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BAIAP2L1 LRRC8A PPP1R13L TRIM29	1.81e-04	187	67	4	a6a112689d1c9049f57935ad9d2f4955538427de
ToppCell	Control-Epithelial-ATI\|Epithelial / Disease state, Lineage and Cell class	MAP2 ATOH8 SUSD2 SCEL	1.81e-04	187	67	4	3a032432f780525f4f4c2a358897d9989b1ecae7
ToppCell	AT1-AT2_cells-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	MAP2 SUSD2 SCEL CTNND2	1.84e-04	188	67	4	be710bc957118cf426dd71c2d57e6f1b41c9a467
ToppCell	facs-MAT-Fat-18m\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTYH2 LRRC8A KDM6B ZYX	1.84e-04	188	67	4	7f0cda7aab442aa9511d4c35569ec2389e014a71
ToppCell	cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	HOXD1 HIF3A RGP1 NCKAP5L	1.88e-04	189	67	4	bccb3481ffed597c845fe860da658505316105b5
ToppCell	COPD-Epithelial-ATI\|Epithelial / Disease state, Lineage and Cell class	MAP2 ATOH8 SUSD2 SCEL	1.88e-04	189	67	4	14e8e57e4db336fbef005270647983b4edf407c0
ToppCell	SupraBC-Differ-KC\|World / shred by cell class for mouse tongue	FOXN1 MAP2 SCEL SERPINA9	1.88e-04	189	67	4	6412741b88e241304033b41effca0c77a374d907
ToppCell	facs-Tongue-nan-3m-Epithelial-suprabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXN1 MAP2 SCEL SERPINA9	1.92e-04	190	67	4	719a5cecc3e8001ca9c38165258b5ff9c800713a
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP2 ATOH8 SUSD2 SCEL	1.96e-04	191	67	4	a15e34ad7dbf3f2f13d5e23ce3ffb6d08fd1f9f0
ToppCell	facs-Skin\|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLCH2 SCEL PPP1R13L TRIM29	1.96e-04	191	67	4	ae524103331fa53fa82888dbb567fc36abcee7e0
ToppCell	facs-Tongue-nan-18m-Epithelial-suprabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXN1 MAP2 SCEL SERPINA9	1.96e-04	191	67	4	02f24202f9fdd46c648265a5b3b6f9066aa009fc
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLCH2 KDM6B TRIM29 NCKAP5L	1.96e-04	191	67	4	2f733d510a4862565a817f59829d8387d7ea26d9
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RANBP9 SCEL PPP1R13L TRIM29	1.96e-04	191	67	4	fbd8d337b4444fba8527a614e4a8bfb516ce0f66
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLCH2 KDM6B TRIM29 NCKAP5L	1.96e-04	191	67	4	8691eba35793e4e90f93d50c2145847ee51289f7
ToppCell	facs-Bladder-nan-18m-Epithelial-bladder_urothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BAIAP2L1 GATA3 LRRC8A TRIM29	2.00e-04	192	67	4	18546b4d5e39aafa97186104d47cfda02eb5f4b5
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ATXN2 HIF3A SRRM2 AFF4	2.00e-04	192	67	4	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MAP2 RTN4 LPP KDM6B	2.00e-04	192	67	4	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	facs-SCAT-Fat-18m\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTYH2 LRRC8A KDM6B SRRM2	2.00e-04	192	67	4	cd004f8b00ebdb7f6d889f58d2cd6cbab4b809dd
ToppCell	AT1_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	MAP2 ATOH8 SUSD2 SCEL	2.00e-04	192	67	4	0444f9e9cef7403e220e862b5a787443d3f5c9ac
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCHSD2 RUBCNL CCDC6 KDM6B	2.04e-04	193	67	4	bbea475d2c4c7b29674ff302529f8f83dd666dcb
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FCHSD2 ZNF609 FAM168A LPP	2.04e-04	193	67	4	779276e775cb2492e8dd36436295a536084a6415
ToppCell	droplet-Bladder-nan-3m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BAIAP2L1 PLCH2 GATA3 TRIM29	2.04e-04	193	67	4	268925bfe85fb94a93a4ff8fe078d692df888140
ToppCell	facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATOH8 ZMIZ1 TRIM29 ZYX	2.04e-04	193	67	4	eba3c70701b051bc1ed1f4db9270cb27a77ffc3e
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	ATXN2 HIF3A SRRM2 AFF4	2.04e-04	193	67	4	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	facs-Bladder-nan-3m-Epithelial-bladder_urothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLCH2 GATA3 CTNND2 TRIM29	2.08e-04	194	67	4	1531dcace28a14bd700e909a027426a8cee20337
ToppCell	facs-Skin-Anagen-3m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATOH8 ZMIZ1 TRIM29 ZYX	2.08e-04	194	67	4	5d30d3d41d5f19cdf3077cc609aa2738762cb8c5
ToppCell	356C-Epithelial_cells-Epithelial-I_(AT1)\|356C / Donor, Lineage, Cell class and subclass (all cells)	MAP2 SUSD2 SCEL CTNND2	2.12e-04	195	67	4	07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP2 ATOH8 SUSD2 SCEL	2.12e-04	195	67	4	68f4cc84b5ae7f4159b780c78e4b66c94211779a
ToppCell	normal_Lung-Epithelial_cells-AT1\|normal_Lung / Location, Cell class and cell subclass	MAP2 ATOH8 SUSD2 SCEL	2.12e-04	195	67	4	569d1ebc5a5aa110a2430b096755ae35354040c4
ToppCell	356C-Epithelial_cells-Epithelial-I_(AT1)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	MAP2 SUSD2 SCEL CTNND2	2.12e-04	195	67	4	b65511770ed67f7447847e2187555b362988af45
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP2 ATOH8 SUSD2 SCEL	2.12e-04	195	67	4	2a1863f4b9fe73c30b0b1acf9b12fc98ef65040f
ToppCell	AT1\|World / shred by cell class for parenchyma	SUSD2 PLCH2 SCEL TRIM29	2.16e-04	196	67	4	2bc487f8a109a6961ebff111dec79c2227ea60ac
ToppCell	Basal_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	PLCH2 LRRC8A PPP1R13L TRIM29	2.16e-04	196	67	4	3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP2 ATOH8 SUSD2 SCEL	2.16e-04	196	67	4	eb68f7954e7c2f86d05e740e95b6e74805a6053f
ToppCell	(7)_Epithelial-I_(AT1)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	MAP2 SUSD2 SCEL CTNND2	2.16e-04	196	67	4	150554fa06868d29b0608189862eef6505ba757f
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ATOH8 CD46 HIF3A RAPGEF2	2.20e-04	197	67	4	66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb
ToppCell	distal-1-Epithelial-Alveolar_Epithelial_Type_1\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MAP2 SUSD2 SCEL CTNND2	2.20e-04	197	67	4	d44b7dc7c6416ed9466889374c3ae39f43ac8bb6
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZNF469 ZMIZ1 KDM6B HCK	2.20e-04	197	67	4	515a2d0ee2bd3fc0a5a0c315e2b0c752e6af7406
ToppCell	ASK452-Epithelial-Type_1\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	MAP2 SUSD2 SCEL PPP1R13L	2.20e-04	197	67	4	dc0a6dca4af6b216357b06f67203274f8b2a8bb0
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FOXN1 LRRC8A PPP1R13L TRIM29	2.20e-04	197	67	4	61c0d78b29dc4ad8a84172cbfcdab03f31351d0e
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZNF469 ZMIZ1 KDM6B HCK	2.20e-04	197	67	4	bfa04e5f4156a01df4217b1f59676edb0a7563e1
ToppCell	normal_Lung-Epithelial_cells-AT1\|Epithelial_cells / Location, Cell class and cell subclass	MAP2 ATOH8 SUSD2 SCEL	2.20e-04	197	67	4	7d19b93d6853828e2a036e37c4887edb1de4503c
ToppCell	Bronchial-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	GREB1L HOXD1 MAP2 BSN	2.20e-04	197	67	4	49689a03ab31e53386dbe15c77c09ca3a14ebf4e
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZNF469 ZMIZ1 KDM6B HCK	2.20e-04	197	67	4	4fccdc69ab4b966de6465f06677435e6f6e6abcd
ToppCell	droplet-Skin-nan-21m-Epithelial-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NACA GATA3 SCEL TRIM29	2.25e-04	198	67	4	e2d1ef4a4c89ce53b47d7d5b8a45e71d3117e1b1
ToppCell	COVID-19-Epithelial-AT2,_AT1_cells\|COVID-19 / Condition, Lineage and Cell class	BAIAP2L1 MAP2 SUSD2 SCEL	2.25e-04	198	67	4	7e6f089e71e70190ff8486341ab06719d7741467
ToppCell	droplet-Skin-nan-21m-Epithelial\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NACA GATA3 SCEL TRIM29	2.25e-04	198	67	4	38a58e6eaae89ce1cadf2e04169c974e13587e50
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP2 LRRC8A TNS2 HIF3A	2.29e-04	199	67	4	a3ec743b978ba8fdf1677b4971b5731f50ddd30f
ToppCell	(08)_Brush+PNEC\|World / shred by cell type by condition	ZNF609 GYS2 ZMIZ1 HCK	2.29e-04	199	67	4	f2e33cb569c25fc2732722cac295647e9bd8738f
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	FCHSD2 ZNF609 LPP RAPGEF2	2.29e-04	199	67	4	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	proximal-Epithelial-Alveolar_Epithelial_Type_1-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MAP2 ATOH8 SUSD2 SCEL	2.33e-04	200	67	4	b652bc73adfdeccbdcd74497ab6e2085e5c95e88
ToppCell	Biopsy_IPF-Epithelial-Basal\|Biopsy_IPF / Sample group, Lineage and Cell type	PLCH2 LRRC8A PPP1R13L TRIM29	2.33e-04	200	67	4	5cea84581201cee7ba8141b96e65864f4fd67113
ToppCell	proximal-3-Epithelial-Basal\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PLCH2 LRRC8A PPP1R13L TRIM29	2.33e-04	200	67	4	8083047c213488e40b975013e3c5c43f7c0c15b2
ToppCell	proximal-Epithelial-Alveolar_Epithelial_Type_1\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MAP2 ATOH8 SUSD2 SCEL	2.33e-04	200	67	4	c1345893e6947ccf9b41282d0e4428dbfb8bcc27
ToppCell	Biopsy_Other_PF-Epithelial-AT1\|Biopsy_Other_PF / Sample group, Lineage and Cell type	MAP2 ATOH8 SUSD2 SCEL	2.33e-04	200	67	4	b746dcc94814bcbca63c71e6451a9c5f084bcfaf
ToppCell	proximal-Epithelial-Basal\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PLCH2 LRRC8A PPP1R13L TRIM29	2.33e-04	200	67	4	c6a491d3e2dae6618f25dc3c9aac08f657348168
ToppCell	proximal-3-Epithelial-Alveolar_Epithelial_Type_1\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MAP2 ATOH8 SUSD2 SCEL	2.33e-04	200	67	4	51f8fc43c069f2c4e75588d28ae6deb5d7ed2c86
ToppCell	proximal-Epithelial-Basal-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PLCH2 LRRC8A PPP1R13L TRIM29	2.33e-04	200	67	4	f5d48f521abbd1e07de05f2b3768ad2f9675f1e1
Computational	Neighborhood of MAP4K4	RTN4 TTYH2 LRRC8A TNS2 ULK2 MAPK8IP3	1.08e-04	172	48	6	GCM_MAP4K4
Computational	Neighborhood of DLG1	RTN4 TNS2 RAPGEF2 MAPK8IP3	4.11e-04	79	48	4	GCM_DLG1
Computational	Neighborhood of PTK2	RTN4 TTYH2 TNS2 ULK2 MAPK8IP3	4.48e-04	145	48	5	GCM_PTK2
Drug	yohimbine; Up 200; 22.9uM; MCF7; HT_HG-U133A_EA	RANBP10 FAM168A LPP CTNND2 KDM6B PPP1R13L SRRM2 ULK2 ZYX	5.49e-09	194	67	9	1119_UP
Drug	Metoclopramide monohydrochloride [7232-21-5]; Up 200; 11.8uM; PC3; HT_HG-U133A	GREB1L HOXD1 LPP SUGP1 CCDC6 TRIM29 HHLA1	1.83e-06	197	67	7	4285_UP
Drug	Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A	FCHSD2 ZNF609 LPP ARHGEF9 SUGP1 TNS2 CTNND2	1.96e-06	199	67	7	2858_DN
Drug	Doxylamine succinate [562-10-7]; Up 200; 10.2uM; HL60; HG-U133A	ZNF609 POLR2A SUGP1 MED14 RAPGEF2 KDM6B PPP1R13L	1.96e-06	199	67	7	1973_UP
Drug	fullerene C60	FOXN1 RANBP10 ZNF609 FAM168A KIF26A ZMIZ2 POLR2A GYS2 TTYH2 ULK1 HIF3A BSN KDM6B AFF4 PRRC2B MAPK8IP3	5.19e-06	1498	67	16	ctd:C069837
Drug	Luteolin [491-70-3]; Down 200; 14uM; PC3; HT_HG-U133A	FCHSD2 ZNF609 SUGP1 KDM6B SRRM2 MAPK8IP3	2.10e-05	191	67	6	6658_DN
Drug	0175029-0000 [211245-78-2]; Up 200; 10uM; PC3; HT_HG-U133A	NACA MED14 CD46 ROBO3 TRIM29 MAPK8IP3	2.16e-05	192	67	6	6875_UP
Drug	Graveoline [485-61-0]; Up 200; 14.4uM; PC3; HT_HG-U133A	GREB1L ZNF609 MAP2 SUGP1 CTNND2 HHLA1	2.23e-05	193	67	6	4276_UP
Drug	Albendazole [54965-21-8]; Up 200; 15uM; MCF7; HT_HG-U133A	ZNF609 MAP2 SUGP1 MED14 ZYX AFF4	2.30e-05	194	67	6	7164_UP
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A	GREB1L ZNF609 GATA3 CD46 CTNND2 MAPK8IP3	2.30e-05	194	67	6	3725_DN
Drug	Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A	GREB1L ZNF609 NRL AMOT ZMIZ2 SUGP1	2.36e-05	195	67	6	4814_UP
Drug	AG-028671 [847803-03-6]; Up 200; 10uM; PC3; HT_HG-U133A	GREB1L ZNF609 PLCH2 SUGP1 TNS2 TRIM29	2.36e-05	195	67	6	6557_UP
Drug	Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; PC3; HT_HG-U133A	ZNF609 FAM168A ZMIZ2 SUGP1 TRIM29 PRRC2B	2.36e-05	195	67	6	2087_UP
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	ZNF609 POLR2A NACA CTNND2 KDM6B TRIM29	2.43e-05	196	67	6	5574_DN
Drug	Isoxicam [34552-84-6]; Up 200; 12uM; PC3; HT_HG-U133A	FCHSD2 ZNF609 CAMKK2 SUGP1 TNS2 SRRM2	2.43e-05	196	67	6	1820_UP
Drug	Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; PC3; HT_HG-U133A	GREB1L ZNF609 ZMIZ2 POLR2A SUGP1 CTNND2	2.43e-05	196	67	6	4281_UP
Drug	Acacetin [480-44-4]; Up 200; 14uM; MCF7; HT_HG-U133A	FAM168A ZMIZ2 ARHGEF9 TNS2 KDM6B SRRM2	2.43e-05	196	67	6	3849_UP
Drug	Monocrotaline [315-22-0]; Down 200; 12.2uM; PC3; HT_HG-U133A	RANBP10 FAM168A POLR2A ARHGEF9 ROBO3 SRRM2	2.43e-05	196	67	6	7127_DN
Drug	Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; HL60; HG-U133A	HOXD1 ATXN2 POLR2A CD46 RAPGEF2 PRRC2B	2.43e-05	196	67	6	1379_DN
Drug	Clorsulon [60200-06-8]; Down 200; 10.6uM; HL60; HG-U133A	FCHSD2 ZNF609 HOXD1 RNF44 POLR2A RGP1	2.43e-05	196	67	6	1735_DN
Drug	Midecamycin [35457-80-8]; Down 200; 5uM; MCF7; HT_HG-U133A	ZNF609 ZMIZ2 TNS2 KDM6B AFF4 MAPK8IP3	2.50e-05	197	67	6	1526_DN
Drug	Oxolinic acid [14698-29-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A	CAMKK2 ZMIZ2 ROBO3 TRIM29 HHLA1 ZYX	2.50e-05	197	67	6	5519_UP
Drug	Nicardipine hydrochloride [54527-84-3]; Down 200; 7.8uM; MCF7; HT_HG-U133A	ZNF609 ARHGEF9 SUGP1 ULK2 ZYX AFF4	2.50e-05	197	67	6	3215_DN
Drug	Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A	ZMIZ2 GATA3 SUGP1 MED14 CTNND2 SRRM2	2.50e-05	197	67	6	3763_DN
Drug	Lithocholic acid [434-13-9]; Up 200; 10.6uM; MCF7; HT_HG-U133A	GREB1L CAMKK2 PLCH2 RUBCNL SUGP1 MAPK8IP3	2.50e-05	197	67	6	3899_UP
Drug	nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A	LPP MED14 RAPGEF2 SRRM2 ZYX MAPK8IP3	2.57e-05	198	67	6	5220_DN
Drug	Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A	ZNF609 FAM168A NRL ZMIZ2 ARHGEF9 SUGP1	2.57e-05	198	67	6	7349_UP
Drug	CP-863187 [668981-07-5]; Up 200; 10uM; MCF7; HT_HG-U133A	RANBP10 ZMIZ2 LPP ARHGEF9 MED14 CTNND2	2.57e-05	198	67	6	7553_UP
Drug	Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; MCF7; HT_HG-U133A	POLR2A TNS2 HIF3A TRIM29 SRRM2 MAPK8IP3	2.65e-05	199	67	6	3541_UP
Drug	Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; PC3; HG-U133A	FAM168A ATXN2 LPP MED14 KDM6B PPP1R13L	2.65e-05	199	67	6	1911_DN
Drug	Levodopa [59-92-7]; Down 200; 20.2uM; HL60; HG-U133A	ATXN2 MED14 CD46 RAPGEF2 PDHX MAPK8IP3	2.65e-05	199	67	6	1972_DN
Drug	genistein; Down 200; 10uM; MCF7; HT_HG-U133A	CAMKK2 LPP TNS2 RAPGEF2 ULK2 ZYX	2.65e-05	199	67	6	1660_DN
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; PC3; HT_HG-U133A	ZNF609 FAM168A SUGP1 KDM6B RGP1 SRRM2	2.65e-05	199	67	6	5789_DN
Drug	Proglumide [6620-60-6]; Down 200; 12uM; PC3; HT_HG-U133A	ZNF609 HOXD1 ZMIZ2 SUGP1 CTNND2 MAPK8IP3	2.65e-05	199	67	6	3780_DN
Drug	LY 294002; Down 200; 10uM; PC3; HT_HG-U133A	ZNF609 ARHGEF9 GATA3 SUGP1 ZYX PRRC2B	2.65e-05	199	67	6	1227_DN
Drug	chlorpromazine hydrochloride; Down 200; 1uM; HL60; HT_HG-U133A	FAM168A ARHGEF9 SUGP1 TNS2 RAPGEF2 CCDC6	2.72e-05	200	67	6	2677_DN
Drug	Ethosuximide [77-67-8]; Up 200; 28.4uM; PC3; HT_HG-U133A	ZMIZ2 GATA3 SUGP1 KDM6B TRIM29 MAPK8IP3	2.72e-05	200	67	6	2116_UP
Drug	alpha-CaM	CAMKK2 MAP2 CTNND2 ZYX	3.36e-05	62	67	4	CID000196705
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	FCHSD2 ZNF609 ATXN2 ZMIZ1 RAPGEF2	1.49e-04	171	67	5	7535_DN
Drug	Niclosamide [50-65-7]; Up 200; 12.2uM; HL60; HG-U133A	LPP NACA RAPGEF2 SRRM2 HCK	1.54e-04	172	67	5	1998_UP
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ZNF609 GATA3 TNS2 ZMIZ1 SRRM2	1.66e-04	175	67	5	6891_DN
Drug	Hycanthone [3105-97-3]; Down 200; 11.2uM; HL60; HG-U133A	LPP NACA SUGP1 CD46 PRRC2B	2.27e-04	187	67	5	1614_DN
Drug	celastrol; Down 200; 2.5uM; MCF7; HT_HG-U133A_EA	FCHSD2 CAMKK2 POLR2A MED14 PRRC2B	2.27e-04	187	67	5	887_DN
Drug	troglitazone; Down 200; 10uM; PC3; HT_HG-U133A	GATA3 SUGP1 MED14 SCEL PPP1R13L	2.32e-04	188	67	5	4456_DN
Drug	Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; HL60; HT_HG-U133A	RANBP10 ZNF609 SUGP1 KDM6B MAPK8IP3	2.32e-04	188	67	5	1865_DN
Drug	Prednisone [53-03-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	ZMIZ2 SUGP1 ROBO3 TRIM29 ULK2	2.38e-04	189	67	5	4400_DN
Drug	Prostaglandin E1; Up 200; 10uM; PC3; HT_HG-U133A	ZNF609 LPP SUGP1 TRIM29 MAPK8IP3	2.44e-04	190	67	5	6555_UP
Drug	Tiabendazole [148-79-8]; Up 200; 19.8uM; MCF7; HT_HG-U133A	GREB1L ZMIZ2 CTNND2 TRIM29 ULK2	2.50e-04	191	67	5	2840_UP
Drug	Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A	ZNF609 SUGP1 MED14 RAPGEF2 KDM6B	2.50e-04	191	67	5	7165_UP
Drug	6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine	MAP2 POLR2A ZMIZ1 KDM6B	2.52e-04	104	67	4	ctd:C000595015
Drug	prazosin hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A_EA	SUGP1 CD46 CCDC6 PPP1R13L MAPK8IP3	2.56e-04	192	67	5	942_DN
Drug	Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; PC3; HT_HG-U133A	MED14 TNS2 KDM6B ZYX PRRC2B	2.62e-04	193	67	5	4186_DN
Drug	Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; MCF7; HT_HG-U133A	ZNF609 FAM168A SUGP1 TNS2 CTNND2	2.62e-04	193	67	5	6783_DN
Drug	Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; PC3; HT_HG-U133A	ZMIZ2 SUGP1 TNS2 KDM6B ZYX	2.62e-04	193	67	5	4241_DN
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; MCF7; HT_HG-U133A	ZMIZ2 SUGP1 TNS2 TRIM29 MAPK8IP3	2.62e-04	193	67	5	6846_UP
Drug	Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A	CAMKK2 POLR2A LPP RAPGEF2 SRRM2	2.68e-04	194	67	5	5362_UP
Drug	Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A	GREB1L HOXD1 ATXN2 GATA3 ROBO3	2.68e-04	194	67	5	3807_DN
Drug	Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	FCHSD2 ZMIZ2 SUGP1 CTNND2 SRRM2	2.68e-04	194	67	5	3280_DN
Drug	Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A	GREB1L POLR2A SRRM2 ULK2 MAPK8IP3	2.68e-04	194	67	5	6835_UP
Drug	5194442; Up 200; 20uM; PC3; HT_HG-U133A	LPP ARHGEF9 SUGP1 MED14 RAPGEF2	2.68e-04	194	67	5	6553_UP
Drug	Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A	GREB1L ZNF609 ZMIZ2 CTNND2 ZYX	2.68e-04	194	67	5	2621_UP
Drug	(-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A	GREB1L KDM6B TRIM29 SRRM2 MAPK8IP3	2.68e-04	194	67	5	3354_DN
Drug	Carbamazepine [298-46-4]; Up 200; 17uM; PC3; HT_HG-U133A	ZNF609 SUGP1 CCDC6 ULK2 AFF4	2.68e-04	194	67	5	1805_UP
Drug	PNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A	ZNF609 ZMIZ2 TNS2 TRIM29 ZYX	2.68e-04	194	67	5	4291_DN
Drug	Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A	ATXN2 SUGP1 RAPGEF2 KDM6B RGP1	2.68e-04	194	67	5	4529_DN
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A	SUGP1 CTNND2 KDM6B ZYX MAPK8IP3	2.75e-04	195	67	5	1657_DN
Drug	CP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A	MAP2 ZMIZ2 SUGP1 TNS2 AFF4	2.75e-04	195	67	5	3909_DN
Drug	Sulfaphenazole [526-08-9]; Down 200; 12.8uM; HL60; HT_HG-U133A	FAM168A CD46 KDM6B PRRC2B MAPK8IP3	2.75e-04	195	67	5	1836_DN
Drug	Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; PC3; HT_HG-U133A	GREB1L ZNF609 GATA3 CTNND2 MAPK8IP3	2.75e-04	195	67	5	4660_DN
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; PC3; HT_HG-U133A	GREB1L ZNF609 LPP HIF3A RAPGEF2	2.75e-04	195	67	5	4298_UP
Drug	Vitexin [3681-93-4]; Down 200; 9.2uM; MCF7; HT_HG-U133A	FAM168A POLR2A TNS2 RAPGEF2 ZYX	2.75e-04	195	67	5	2810_DN
Drug	Nialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A	MAP2 ARHGEF9 TNS2 TRIM29 MAPK8IP3	2.75e-04	195	67	5	3871_DN
Drug	ST021200; Up 200; 10uM; MCF7; HT_HG-U133A	ZNF609 LPP ARHGEF9 MED14 CD46	2.75e-04	195	67	5	7554_UP
Drug	Procyclidine hydrochloride [1508-76-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A	ZNF609 ZMIZ2 SUGP1 TRIM29 ZYX	2.75e-04	195	67	5	4817_UP
Drug	Lisinopril [83915-83-7]; Up 200; 9uM; MCF7; HT_HG-U133A	GREB1L FCHSD2 ZNF609 SUGP1 ULK2	2.75e-04	195	67	5	7403_UP
Drug	Zimelidine dihydrochloride monohydrate [61129-30-4]; Up 200; 9.8uM; PC3; HG-U133A	ATXN2 RANBP9 TNS2 TRIM29 HHLA1	2.81e-04	196	67	5	1930_UP
Drug	Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; MCF7; HT_HG-U133A	RANBP10 ZMIZ2 SUGP1 AFF4 MAPK8IP3	2.81e-04	196	67	5	4718_DN
Drug	(S)-(-)-Cycloserine [339-72-0]; Up 200; 39.2uM; PC3; HT_HG-U133A	LPP GATA3 SUGP1 CTNND2 AFF4	2.81e-04	196	67	5	4524_UP
Drug	Cyproterone acetate [427-51-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A	GREB1L FOXN1 ZNF609 SUGP1 RAI1	2.81e-04	196	67	5	3545_UP
Drug	Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; MCF7; HT_HG-U133A	PLCH2 ZMIZ2 TRIM29 HHLA1 MAPK8IP3	2.81e-04	196	67	5	3371_UP
Drug	Probucol [23288-49-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A	ZNF609 ARHGEF9 SUGP1 TNS2 ZYX	2.81e-04	196	67	5	5261_DN
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A	RANBP10 ZNF609 ARHGEF9 SUGP1 RAPGEF2	2.81e-04	196	67	5	1629_DN
Drug	Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A	SUGP1 MED14 ROBO3 KDM6B ZYX	2.81e-04	196	67	5	4227_DN
Drug	estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA	ZMIZ2 MED14 TNS2 RGP1 ULK2	2.81e-04	196	67	5	1021_DN
Drug	Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; PC3; HT_HG-U133A	ZMIZ2 SUGP1 SRRM2 ULK2 AFF4	2.81e-04	196	67	5	6637_DN
Drug	sodium 4-phenylbutyrate; Up 200; 100uM; HL60; HG-U133A	AMOT LPP HIF3A KDM6B TRIM29	2.81e-04	196	67	5	363_UP
Drug	PF-00539745-00 [351321-33-0]; Down 200; 10uM; MCF7; HT_HG-U133A	ZMIZ2 SUGP1 RAPGEF2 TRIM29 MAPK8IP3	2.81e-04	196	67	5	5974_DN
Drug	Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A	ZNF609 SUGP1 CTNND2 ZYX PRRC2B	2.81e-04	196	67	5	5341_UP
Drug	6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; HL60; HT_HG-U133A	RANBP10 SUGP1 MED14 RAPGEF2 KDM6B	2.81e-04	196	67	5	2925_DN
Drug	ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA	GREB1L ZMIZ2 SUGP1 TNS2 SCEL	2.81e-04	196	67	5	918_UP
Drug	Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; PC3; HT_HG-U133A	ARHGEF9 SUGP1 CTNND2 SRRM2 PRRC2B	2.88e-04	197	67	5	4604_DN
Drug	Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; PC3; HT_HG-U133A	GATA3 SUGP1 KDM6B TRIM29 AFF4	2.88e-04	197	67	5	2059_UP
Drug	Etofylline [519-37-9]; Down 200; 17.8uM; PC3; HT_HG-U133A	NACA CCDC6 KDM6B ZYX PRRC2B	2.88e-04	197	67	5	2093_DN
Drug	Ajmaline [4360-12-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A	ZNF609 FAM168A ZMIZ2 SUGP1 TNS2	2.88e-04	197	67	5	7484_UP
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	ZMIZ2 SUGP1 ROBO3 RAPGEF2 SRRM2	2.88e-04	197	67	5	2326_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A	ZNF609 HOXD1 KDM6B PPP1R13L SRRM2	2.88e-04	197	67	5	1732_DN
Drug	ICI 182,780; Up 200; 1uM; MCF7; HG-U133A	GREB1L RANBP10 ZNF609 SUGP1 RGP1	2.88e-04	197	67	5	367_UP
Drug	Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; PC3; HT_HG-U133A	GATA3 SUGP1 KDM6B SRRM2 MAPK8IP3	2.88e-04	197	67	5	6700_DN
Drug	Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A	FAM168A CTNND2 ROBO3 RGP1 ZYX	2.88e-04	197	67	5	2235_DN
Drug	(+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A	GREB1L ZMIZ2 TRIM29 SRRM2 ZYX	2.88e-04	197	67	5	3355_DN
Disease	anthropometric measurement	ZNF469 ATXN2 POLR2A ZMIZ1 BSN	3.28e-05	168	64	5	EFO_0004302
Disease	interleukin-23 measurement	ATXN2 LPP	6.91e-05	6	64	2	EFO_0020501
Disease	serum gamma-glutamyl transferase measurement	CAMKK2 PCNX3 ZMIZ2 GYS2 ULK1 ZMIZ1 POM121C ZYX PDHX	1.51e-04	914	64	9	EFO_0004532
Disease	mean platelet volume	PCNX3 ATXN2 ZMIZ2 POLR2A GYS2 NACA LRRC8A ZMIZ1 ULK2	3.40e-04	1020	64	9	EFO_0004584
Disease	Genetic chronic primary adrenal insufficiency	ATXN2 LPP	3.56e-04	13	64	2	Orphanet_101960
Disease	Crohn's disease	FCHSD2 ATXN2 LPP HIF3A ZMIZ1 BSN	3.88e-04	441	64	6	EFO_0000384
Disease	nodular sclerosis Hodgkin lymphoma	LPP GATA3	4.14e-04	14	64	2	EFO_0004708
Disease	obsolete_interleukin-12 subunit B measurement	ATXN2 LPP	4.14e-04	14	64	2	EFO_0010787
Disease	neuroimaging measurement	ZNF469 MAP2 ATXN2 ROBO3 RAPGEF2 RGP1 POM121C RAI1 MAPK8IP3	4.78e-04	1069	64	9	EFO_0004346
Disease	susceptibility to childhood ear infection measurement	GATA3 CTNND2 BSN RAI1	5.28e-04	171	64	4	EFO_0007904
Disease	Feeding difficulties	POLR2A ZMIZ1	6.93e-04	18	64	2	C0232466
Disease	monocyte percentage of leukocytes	BAIAP2L1 ATXN2 LPP ZMIZ1 CCDC6 KDM6B ZYX	1.02e-03	731	64	7	EFO_0007989
Disease	C-reactive protein measurement	ZNF469 CAMKK2 ZMIZ2 GYS2 HIF3A ZMIZ1 BSN AFF4 MAPK8IP3	1.13e-03	1206	64	9	EFO_0004458
Disease	lymphocyte count	RANBP10 ZNF469 BAIAP2L1 ATXN2 RTN4 LPP GATA3 HIF3A ZMIZ1 RAI1	1.15e-03	1464	64	10	EFO_0004587
Disease	Vitiligo	ATXN2 LPP ZMIZ1	1.39e-03	101	64	3	EFO_0004208
Disease	glucose measurement	ATXN2 ZMIZ2 RTN4 BSN PDHX	1.41e-03	380	64	5	EFO_0004468
Disease	Hashimoto's thyroiditis	ATXN2 LPP	1.46e-03	26	64	2	EFO_0003779
Disease	eye measurement	ZNF469 ATXN2	1.57e-03	27	64	2	EFO_0004731
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	RANBP10 ATXN2 SUGP1 RAI1	1.94e-03	243	64	4	EFO_0004612, EFO_0020944
Disease	Ovarian Mucinous Adenocarcinoma	ULK1 HCK	2.07e-03	31	64	2	C1335167
Disease	fear of minor pain measurement	RAPGEF2 HCK	2.07e-03	31	64	2	EFO_0008340
Disease	JT interval	LPP NACA ZMIZ1 RAI1	2.08e-03	248	64	4	EFO_0007885

Protein segments in the cluster

Peptide	Gene	Start	Entry
PPQPNDLYKNPTSSS	AMOT	201	Q4VCS5
PSIPNSAGKLTRPSY	CXorf66	146	Q5JRM2
TSPPTTEGFKYPRPS	GYS2	626	P54840
YTPSPSSSRPISPGL	CCDC6	356	Q16204
TYAAPRGSSPKQSPS	CTNND2	291	Q9UQB3
PSSQTPKYPESNRTP	AFF4	661	Q9UHB7
KGVNSARSVPPSYPP	ARHGEF9	456	O43307
RSPKSQDSYPVSPRP	RANBP9	466	Q96S59
GRSPSYSSTPSPLMP	RAI1	351	Q7Z5J4
PKSQDSYPGSPSLSP	RANBP10	356	Q6VN20
SLPTSPGILATSPYP	RUBCNL	146	Q9H714
YPNSTILPTPDTGPT	LRRC8A	81	Q8IWT6
PAPPTRPGESSYSSI	ATOH8	181	Q96SQ7
ASSASGPRPTYKPPV	CD46	311	P15529
GTPYKVPPTQSNTAP	FAM168A	106	Q92567
SSSSSPPPAKRPYPS	MAPK8IP3	581	Q9UPT6
AQGLPTSPSPCYTTP	NCKAP5L	516	Q9HCH0
ASPAPGTYPKSVSPA	HOXD1	181	Q9GZZ0
CPSPSSRPPSRYQSG	ATXN2	556	Q99700
STRPGPLPTTQYSPG	KDM6B	826	O15054
PDRGSTPTSPYSVPQ	BSN	146	Q9UPA5
PPKRPYGTQRTPSTA	PCNX3	481	Q9H6A9
PTAPSPLQATAGPSY	PDHX	241	O00330
RPGPPTASLGSTPYS	NRL	31	P54845
PYKPRPPQSSTGSTA	LPP	136	Q93052
PPPATRGTSTYPTDF	KIF26A	326	Q9ULI4
SDSNSPPIPYSQKPA	GREB1L	96	Q9C091
KQPGTSGAYPLTSPP	MED14	1011	O60244
SSAKSPLPSYPGANP	POM121C	931	A8CG34
SPGPLSVYPPASSSS	GATA3	126	P23771
YVPDPTSTIKPGPNS	HCK	51	P08631
SPKMPPAPSGRAYTS	BAIAP2L1	281	Q9UHR4
YNGKRTSSPRSPPSS	MCRIP1	11	C9JLW8
LPYSPVSSPQSSPRL	CAMKK2	126	Q96RR4
QPPSSPYPSPDKRSS	FCHSD2	661	O94868
AGPPSRPPRYSSSSI	PPP1R13L	61	Q8WUF5
SLPSSYRPAQPSPSA	PCARE	1011	A6NGG8
GRPQPPTLDPTSTSY	PCARE	1201	A6NGG8
SSSDSPPRPQPAFKY	RTN4	11	Q9NQC3
GTQTPSPTKATAPRY	HHLA1	396	C9JL84
NSGSFTFTPKPAPPS	SUSD2	226	Q9UGT4
TPKGGVRTSYQPSSP	TRIM29	476	Q14134
TPPTAANYPSSSRTP	SRRM2	2316	Q9UQ35
PTSPTLASYAAPGPS	RGP1	371	Q92546
PAGPSVYLSPSSKPV	FOXN1	631	O15353
RAYKPPAQTSPAGSP	HIF3A	196	Q9Y2N7
APSAYPRPSSTKSTP	SERPINA9	26	Q86WD7
PETSSGYSDPQPAPK	SPANXC	26	Q9NY87
SAPPSTPTPSAGKRS	SUGP1	111	Q8IWZ8
SPPTSPQSSPRKGYT	RAPGEF2	1116	Q9Y4G8
PETSSGYSDPQPAPK	SPANXD	26	Q9BXN6
GRASPPPTYSPSMRA	TTYH2	501	Q9BSA4
AVPTSSSQGRPPYPT	PLCH2	1021	O75038
PPPPGYNASSSTGTR	SCEL	166	O95171
PSRRETPSPTPSYGQ	ROBO3	1136	Q96MS0
YSTSAPGPALSPSVP	RNF44	236	Q7L0R7
SPTSPKGSTYSPTSP	POLR2A	1931	P24928
ASQQGSTPSLYPPPR	ZNF609	1396	O15014
VPSPQTYRPSSASPS	PRRC2B	2151	Q5JSZ5
ITPGTPPSYSSRTPG	MAP2	1601	P11137
SRTPGTPGTPSYPRT	MAP2	1611	P11137
SYPRTPHTPGTPKSA	MAP2	1621	P11137
SGPTRSIPGYPSSPL	ZMIZ2	356	Q8NF64
PQSRGTSPLQPGSYP	ZNF469	211	Q96JG9
YSPQPSRPGSLGTSP	ULK2	561	Q8IYT8
GYVPPPVATPFSSKS	ZYX	171	Q15942
KSPPVPVPSYPSSGS	ULK1	286	O75385
ISPGSPPYPQSRKLS	TNS2	831	Q63HR2
TPGSSIPPYLSPSQD	ZMIZ1	521	Q9ULJ6
SPPAVTPSTYKGAPS	NACA	1581	E9PAV3